Overview
- Editors:
-
-
Akitane Mori
-
Inst. for Neurobiology, Okayama University Medical School, Okayama 700, Japan
-
B. D. Cohen
-
The Bronx Lebanon Hospital Center, Bronx, USA
-
A. Lowenthal
-
Laboratory of Neurochemistry, Born-Bunge Foundation, Universitaire Instelling Antwerpen, Wilrijk, Belgium
Access this book
Other ways to access
Table of contents (38 chapters)
-
Metabolism of Guanidino Compound in Normal and Abnormal Organs, and in Metabolic Diseases
-
- B. Marescau, I. A. Qureshi, P. De Deyn, J. Letarte, M. Yoshino, A. Lowenthal
Pages 171-180
-
- Naoki Mizutani, Mitsuo Maehara, Chiemi Hayakawa, Tomoaki Kato, Kazuyoshi Watanabe, Sakae Suzuki
Pages 181-193
-
Physiological, Pharmacological and Toxicological Aspects of Guanidino Compound
-
Front Matter
Pages 195-195
-
- Masamitsu Fujii, Akio Ando, Hiroshi Mikami, Akira Okada, Enyu Imai, Yukifumi Kokuba et al.
Pages 197-204
-
- Hiroshi Mikami, Akio Ando, Masamitsu Fujii, Akira Okada, Enyu Imai, Yukifumi Kokuba et al.
Pages 205-212
-
- R. J. Huxtable, D. Bonhaus, K. Nakagawa, H. E. Laird, H. Pasantes-Morales
Pages 213-225
-
- Kanji Izumi, Chikara Kishita, Takeshi Koja, Takao Shimizu, Takeo Fukuda, Ryan J. Huxtable
Pages 227-234
-
- Midori Hiramatsu, Hideaki Kabuto, Akitane Mori
Pages 235-247
-
- Isao Yokoi, Junji Toma, Akitane Mori
Pages 249-261
-
Involvement of Guanidino Compound in Acute and Chronic Renal Failure
-
Front Matter
Pages 263-263
-
-
- S. Owada, S. Ozawa, M. Inouchi, Y. Kimura, M. Ishida
Pages 277-285
-
- Yoshinori Kōsogabe, Yōji Ochiai, Rikiya Matsuda, Kyoko Nishitani, Shinya Abe, Yoshitarō Itano et al.
Pages 287-294
-
- Fumitake Gejyo, Sadao Baba, Yoko Watanabe, Bellamkonda K. Kishore, Yasushi Suzuki, Masaaki Arakawa
Pages 295-308
-
- Y. Tsubakihara, N. Iida, S. Yuasa, T. Kawashima, I. Nakanishi, M. Tomobuchi et al.
Pages 309-316
-
- Yōji Ochiai, Rikiya Matsuda, Kyōko Nishitani, Yoshinori Kōsogabe, Shinya Abe, Yoshitarō Itano et al.
Pages 317-325
-
- Hideo Itabashi, Hisaki Rinno, Hikaru Koide
Pages 327-334
-
- Seiji Fujiwara, Toshiyuki Nakano, Kazuo Isoda, Tadashi Miayahara
Pages 335-341
-
- Mitsuhiro Miyazaki, Kazumasa Aoyagi, Shoji Ohba, Sohji Nagase, Mitsuharu Narita, Shizuo Tojo
Pages 343-351
-
- Makoto Ishizaki, Hiroshi Kitamura, Hisashi Takahashi, Hisako Asano, Kazuaki Miura, Hajime Okazaki
Pages 353-363
About this book
In 1978, we had the first research meeting of guanidine compound analysis in Okayama, Japan. The purpose of the meeting was to standardize the methods of analyzing guanidino compounds, because the analytic methods, even, for example, that of normal plasma, were quite different from laboratory to laboratory at that time. More than ten laboratories joined in this research project. Thereafter, the purpose of the annual meetings was extended to cover general biochemistry of guanidino compounds, and every meeting has served to promote our mutual growth and progress. The last meeting of the Japan Guanidino Compounds Research Association in 1982 brought together more than 80 members, and about 30 papers were presented there. This, the 6th annual meeting, brings the International Symposium on Guani dino Compounds here to Tokyo. Recently, many scientists are engaged in the research of guanidine compounds, especially in the field of clinical bio chemistry. I am sure that the observation of guanidinosuccinic acid in the urine of uremic patients by Dr. Cohen's research group in 1963 ignited the recent exploration of the role of guanidino compounds in renal diseases. The study of guanidino compounds does, however, have a long history. The first knowledge of guanidine was obtained by Strecker in 1861 (Annalen der Chemie und Pharmacie, 118, 151- 177, 1981).
Editors and Affiliations
-
Inst. for Neurobiology, Okayama University Medical School, Okayama 700, Japan
Akitane Mori
-
The Bronx Lebanon Hospital Center, Bronx, USA
B. D. Cohen
-
Laboratory of Neurochemistry, Born-Bunge Foundation, Universitaire Instelling Antwerpen, Wilrijk, Belgium
A. Lowenthal